The role of Swarna Bhasma in the treatment of Autoimmune disease
Abstract
According to Ayurveda point of view Swarna Bhasma is considered as the best medicine for various disease. Swarna Bhasma is frequently used in the treatment of autoimmune disorder. It is considered as best remedy in the treatment of rheumatoid arthritis, Ankylosing Spondolosis, SLE (Systemic lupus erythematosus), Multiple sclerosis, GBS (Guillen Barry Syndrome), Myasthenia gravis etc. The Karma of Swarna Bhasma is Vrishya, Brimhana, Medhya, Hridya, Balya, Rasayan, Vajikarana, Smritiprada, Tridoshaghana, Yogwahi, Chkshusya, Ojovridhhikara etc. The indication of Swarna Bhasma is in Prameha, Rajayakshama, Unmada, Jwara, Pandu, Swasa, Kasa, Aruchi, Agnimandya, phthisis, loss of vitality, burning sensation, acidity, microbial infection, toxicity, infertility etc. It can be used in all diseases along with different adjuvants or other medium or herb to speed up the recovery process and to increase the body resistance diseases. Swarna Bhasma is potent antitoxin, immunomodulatory, nootropic, antirheumatic, antimicrobial and antiviral in addition. It is also a nervine tonic. Swarna Bhasma overall acts on all organs in the body, especially it acts on nerves, brain, lungs.
Downloads
References
Kaya Chikitsa – Dr. Ajay Kumar Pandey. Chaukhambha Publication, New Dehli
The role of Swarna Bhasma and Kokilaksa in the management of Ksina Sukra (oligospermia) by Dr. Anoop B Thakar (MD Ayu) PG Scholar, Department of Kaya Chikitsa, Gujarat Ayurved University Jamnagar 1999
Swarna Bhasma and gold compounds: An innovation of pharmaceutics for illumination of therapeutics- Singh Neetu, Chaudhary Anand, IJRAP.
https://www.ncpi.nlm.nih.gov.>PMC blood compatibility studies of Swarna Bhasma
Copyright (c) 2021 Shraddha Sharma, Swatantra Kumar Chorasia, Arvind Kumar Yadav
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Ayurveda and Integrated Medical Sciences (JAIMS) retains the copyright of the contents of this journal but grant the readers the right to use the contents with terms and conditions under a creative common attribution licenses 4 of Attribution, Share Alike and Non-commercial type (CC BY-NC-SA) that allows copy, distribute, display, and perform the work and make derivative works based on it only for non-commercial purposes.
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.